Sam Chun Dang Pharm. Co. Ltd (000250) — Capital Reinvestment Ratio
Latest as of March 2025:
8.14x
Sam Chun Dang Pharm. Co. Ltd (000250) has a Capital Reinvestment Ratio of 8.14x as of March 2025, meaning it reinvests 8% of its operating cash flow (₩1.23 Billion) in capital expenditures (₩9.97 Billion). See Sam Chun Dang Pharm. Co. Ltd (000250) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
8.14x
Capex / Operating Cash Flow
Operating Cash Flow
₩1.23 Billion
KRW
Capital Expenditures
₩9.97 Billion
KRW
Data as of
Mar 2025
Most recent filing
Sam Chun Dang Pharm. Co. Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks Sam Chun Dang Pharm. Co. Ltd's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Sam Chun Dang Pharm. Co. Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for Sam Chun Dang Pharm. Co. Ltd from 2012 to 2024. For live market cap and broader valuation context, see Sam Chun Dang Pharm. Co. Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.90x | ₩21.77 Billion | ₩41.30 Billion | ▲ +102.3% |
| 2023 | 0.94x | ₩23.43 Billion | ₩21.97 Billion | ▼ -73.2% |
| 2022 | 3.51x | ₩13.28 Billion | ₩46.55 Billion | ▲ +31.3% |
| 2020 | 2.67x | ₩3.25 Billion | ₩8.68 Billion | ▲ +1139.4% |
| 2019 | 0.22x | ₩30.60 Billion | ₩6.59 Billion | ▼ -53.3% |
| 2018 | 0.46x | ₩25.03 Billion | ₩11.55 Billion | ▲ +270.1% |
| 2017 | 0.12x | ₩26.09 Billion | ₩3.25 Billion | ▼ -75.7% |
| 2016 | 0.51x | ₩17.76 Billion | ₩9.11 Billion | ▼ -19.0% |
| 2015 | 0.63x | ₩17.34 Billion | ₩10.97 Billion | ▲ +41.9% |
| 2014 | 0.45x | ₩19.55 Billion | ₩8.72 Billion | ▲ +65.9% |
| 2013 | 0.27x | ₩15.94 Billion | ₩4.28 Billion | ▼ -84.9% |
| 2012 | 1.79x | ₩1.60 Billion | ₩2.86 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow